Skip to main content
Top
Published in: Endocrine 1/2016

01-04-2016 | Editorial

Skeletal health in adult growth hormone deficiency

Author: Nicholas A. Tritos

Published in: Endocrine | Issue 1/2016

Login to get access

Excerpt

It has been several decades since the seminal experimental studies of Harris and Heaney suggested that growth hormone (GH) has a relevant role in skeletal health [1]. Early clinical studies primarily explored the role of GH replacement in linear bone growth, using GH of human cadaveric origin [2]. At that time, GH was available in scarce quantities which were rationed for the treatment of GH-deficient children and adolescents. With the availability of recombinant human GH in practically unlimited quantities, it became possible to study the effects of GH replacement in adults in the past 2 decades. Several studies have shed light on the phenotype of GH-deficient adults and the effects of GH replacement, but have provided relatively limited information regarding the vertebral fracture risk in patients receiving GH replacement. …
Literature
1.
go back to reference W.H. Harris, R.P. Heaney, Effect of growth hormone on skeletal mass in adult dogs. Nature 223(5204), 403–404 (1969)CrossRefPubMed W.H. Harris, R.P. Heaney, Effect of growth hormone on skeletal mass in adult dogs. Nature 223(5204), 403–404 (1969)CrossRefPubMed
2.
go back to reference M.S. Raben, Treatment of a pituitary dwarf with human growth hormone. J. Clin. Endocrinol. Metab. 18(8), 901–903 (1958)CrossRefPubMed M.S. Raben, Treatment of a pituitary dwarf with human growth hormone. J. Clin. Endocrinol. Metab. 18(8), 901–903 (1958)CrossRefPubMed
3.
go back to reference G. Mazziotti, M. Doga, S. Frara, F. Maffezzoni, T. Porcelli, L. Cerri, R. Maroldi, A. Giustina, Incidence of morphometric vertebral fractures in adult patients with growth hormone deficiency. Endocrine (2015). doi:10.1007/s12020-015-0738-z PubMed G. Mazziotti, M. Doga, S. Frara, F. Maffezzoni, T. Porcelli, L. Cerri, R. Maroldi, A. Giustina, Incidence of morphometric vertebral fractures in adult patients with growth hormone deficiency. Endocrine (2015). doi:10.​1007/​s12020-015-0738-z PubMed
4.
go back to reference G. Mazziotti, A. Bianchi, S. Bonadonna, M. Nuzzo, V. Cimino, A. Fusco, L. De Marinis, A. Giustina, Increased prevalence of radiological spinal deformities in adult patients with GH deficiency: influence of GH replacement therapy. J. Bone Miner. Res. 21(4), 520–528 (2006)CrossRefPubMed G. Mazziotti, A. Bianchi, S. Bonadonna, M. Nuzzo, V. Cimino, A. Fusco, L. De Marinis, A. Giustina, Increased prevalence of radiological spinal deformities in adult patients with GH deficiency: influence of GH replacement therapy. J. Bone Miner. Res. 21(4), 520–528 (2006)CrossRefPubMed
5.
go back to reference P. Vestergaard, J.O. Jorgensen, C. Hagen, H.C. Hoeck, P. Laurberg, L. Rejnmark, K. Brixen, J. Weeke, M. Andersen, F.L. Conceicao, T.L. Nielsen, L. Mosekilde, Fracture risk is increased in patients with GH deficiency or untreated prolactinomas–a case-control study. Clin. Endocrinol. (Oxf) 56(2), 159–167 (2002)CrossRef P. Vestergaard, J.O. Jorgensen, C. Hagen, H.C. Hoeck, P. Laurberg, L. Rejnmark, K. Brixen, J. Weeke, M. Andersen, F.L. Conceicao, T.L. Nielsen, L. Mosekilde, Fracture risk is increased in patients with GH deficiency or untreated prolactinomas–a case-control study. Clin. Endocrinol. (Oxf) 56(2), 159–167 (2002)CrossRef
6.
go back to reference C. Wuster, R. Abs, B.A. Bengtsson, H. Bennmarker, U. Feldt-Rasmussen, E. Hernberg-Stahl, J.P. Monson, B. Westberg, P. Wilton, The influence of growth hormone deficiency, growth hormone replacement therapy, and other aspects of hypopituitarism on fracture rate and bone mineral density. J. Bone Miner. Res. 16(2), 398–405 (2001)CrossRefPubMed C. Wuster, R. Abs, B.A. Bengtsson, H. Bennmarker, U. Feldt-Rasmussen, E. Hernberg-Stahl, J.P. Monson, B. Westberg, P. Wilton, The influence of growth hormone deficiency, growth hormone replacement therapy, and other aspects of hypopituitarism on fracture rate and bone mineral density. J. Bone Miner. Res. 16(2), 398–405 (2001)CrossRefPubMed
8.
go back to reference R. Bouillon, E. Koledova, O. Bezlepkina, J. Nijs, E. Shavrikhova, E. Nagaeva, O. Chikulaeva, V. Peterkova, I. Dedov, A. Bakulin, V. Oganov, A.F. Attanasio, Bone status and fracture prevalence in Russian adults with childhood-onset growth hormone deficiency. J. Clin. Endocrinol. Metab. 89(10), 4993–4998 (2004). doi:10.1210/jc.2004-0054 CrossRefPubMed R. Bouillon, E. Koledova, O. Bezlepkina, J. Nijs, E. Shavrikhova, E. Nagaeva, O. Chikulaeva, V. Peterkova, I. Dedov, A. Bakulin, V. Oganov, A.F. Attanasio, Bone status and fracture prevalence in Russian adults with childhood-onset growth hormone deficiency. J. Clin. Endocrinol. Metab. 89(10), 4993–4998 (2004). doi:10.​1210/​jc.​2004-0054 CrossRefPubMed
9.
go back to reference M. Barake, A. Klibanski, N.A. Tritos, Effects of recombinant human growth hormone therapy on bone mineral density in adults with growth hormone deficiency: a meta-analysis. J. Clin. Endocrinol. Metab. 99(3), 852–860 (2014). doi:10.1210/jc.2013-3921 PubMed M. Barake, A. Klibanski, N.A. Tritos, Effects of recombinant human growth hormone therapy on bone mineral density in adults with growth hormone deficiency: a meta-analysis. J. Clin. Endocrinol. Metab. 99(3), 852–860 (2014). doi:10.​1210/​jc.​2013-3921 PubMed
10.
go back to reference M. Elbornsson, G. Gotherstrom, I. Bosaeus, B.A. Bengtsson, G. Johannsson, J. Svensson, Fifteen years of GH replacement increases bone mineral density in hypopituitary patients with adult-onset GH deficiency. Eur. J. Endocrinol. 166(5), 787–795 (2012). doi:10.1530/EJE-11-1072 CrossRefPubMedPubMedCentral M. Elbornsson, G. Gotherstrom, I. Bosaeus, B.A. Bengtsson, G. Johannsson, J. Svensson, Fifteen years of GH replacement increases bone mineral density in hypopituitary patients with adult-onset GH deficiency. Eur. J. Endocrinol. 166(5), 787–795 (2012). doi:10.​1530/​EJE-11-1072 CrossRefPubMedPubMedCentral
Metadata
Title
Skeletal health in adult growth hormone deficiency
Author
Nicholas A. Tritos
Publication date
01-04-2016
Publisher
Springer US
Published in
Endocrine / Issue 1/2016
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-016-0859-z

Other articles of this Issue 1/2016

Endocrine 1/2016 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.